AU2001279193A1 - Methods and compositions for the construction and use of viral envelops as display particles - Google Patents
Methods and compositions for the construction and use of viral envelops as display particlesInfo
- Publication number
- AU2001279193A1 AU2001279193A1 AU2001279193A AU7919301A AU2001279193A1 AU 2001279193 A1 AU2001279193 A1 AU 2001279193A1 AU 2001279193 A AU2001279193 A AU 2001279193A AU 7919301 A AU7919301 A AU 7919301A AU 2001279193 A1 AU2001279193 A1 AU 2001279193A1
- Authority
- AU
- Australia
- Prior art keywords
- compositions
- construction
- methods
- display particles
- envelops
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000010276 construction Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/73—Fusion polypeptide containing domain for protein-protein interaction containing coiled-coiled motif (leucine zippers)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22269700P | 2000-08-02 | 2000-08-02 | |
US60/222,697 | 2000-08-02 | ||
PCT/US2001/024535 WO2002010417A2 (en) | 2000-08-02 | 2001-08-02 | Methods and compositions for the construction and use of viral envelops as display particles |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001279193A1 true AU2001279193A1 (en) | 2002-02-13 |
Family
ID=22833308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001279193A Abandoned AU2001279193A1 (en) | 2000-08-02 | 2001-08-02 | Methods and compositions for the construction and use of viral envelops as display particles |
Country Status (3)
Country | Link |
---|---|
US (1) | US20020137022A1 (en) |
AU (1) | AU2001279193A1 (en) |
WO (1) | WO2002010417A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100311954A1 (en) * | 2002-03-01 | 2010-12-09 | Xencor, Inc. | Optimized Proteins that Target Ep-CAM |
US7642340B2 (en) | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
WO2004089421A2 (en) * | 2003-03-31 | 2004-10-21 | Xencor, Inc | Methods for rational pegylation of proteins |
US7610156B2 (en) * | 2003-03-31 | 2009-10-27 | Xencor, Inc. | Methods for rational pegylation of proteins |
EP2221315A1 (en) * | 2003-12-04 | 2010-08-25 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
US7557190B2 (en) | 2005-07-08 | 2009-07-07 | Xencor, Inc. | Optimized proteins that target Ep-CAM |
US8969539B2 (en) * | 2008-06-11 | 2015-03-03 | Jn Biosciences Llc | Expression vectors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0349578B2 (en) * | 1987-03-02 | 1998-10-28 | Enzon Labs Inc. | Organism carrying a Single Chain Antibody Domain at its surface. |
AU685753B2 (en) * | 1992-09-04 | 1998-01-29 | Scripps Research Institute, The | Phagemids coexpressing a surface receptor and a surface heterologous protein |
US6475806B1 (en) * | 1995-06-07 | 2002-11-05 | Praecis Pharmaceuticals, Inc. | Anchor libraries and identification of peptide binding sequences |
WO1999025818A1 (en) * | 1997-11-17 | 1999-05-27 | Peter Kufer | Method of identifying binding site domains that retain the capacity of binding to an epitope |
AU4335099A (en) * | 1998-06-18 | 2000-01-05 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Surface targeted expression of a modified hepatitis c virus envelope protein |
JP2002523053A (en) * | 1998-07-30 | 2002-07-30 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | Targeted alphaviruses and alphavirus vectors |
EP1224301A2 (en) * | 1999-10-08 | 2002-07-24 | Biofocus Discovery Limited | Methods and compositions for targeting a cell |
-
2001
- 2001-08-02 AU AU2001279193A patent/AU2001279193A1/en not_active Abandoned
- 2001-08-02 WO PCT/US2001/024535 patent/WO2002010417A2/en active Application Filing
- 2001-08-02 US US09/922,503 patent/US20020137022A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002010417A3 (en) | 2002-10-17 |
WO2002010417A2 (en) | 2002-02-07 |
US20020137022A1 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
AU2001290257A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same | |
AU2003277103A1 (en) | Creamer compositions and methods of making and using the same | |
AU2000279411A1 (en) | New pigments and compositions containing them | |
AU2002306269A1 (en) | N-arylphenylacetamide derivatives and pharmaceutical composition containing the same | |
AU2002357119A1 (en) | Mitocidal compositions and methods | |
AU2001234437A1 (en) | Deicing compositions and methods of use | |
AU1080901A (en) | Catalyst compositions employing sol particles and methods of using the same | |
AU2001280604A1 (en) | Compositions comprising icariside i and anhydroicaritin and methods for making the same | |
AU2001278821A1 (en) | Novel thiocarbamic acid derivatives and the pharmaceutical compositions containing the same | |
AU2001240018A1 (en) | Adeno-associated viral compositions and methods | |
AU2001292047A1 (en) | Composition containing an azaphthalocyanine and use | |
AU2002357748A1 (en) | Osteopontin-related compositions and methods | |
AU2756301A (en) | Compositions comprising genome segments and methods of using the same | |
AU1152601A (en) | Compositions and their use | |
AU2001279193A1 (en) | Methods and compositions for the construction and use of viral envelops as display particles | |
AU2001255580A1 (en) | Methods and compositions for the diagnosis of schizophrenia | |
AU6094200A (en) | Nor gene compositions and methods for use thereof | |
AU4839100A (en) | Methods of using and compositions comprising n-desmethylzolpidem | |
AU2001242019A1 (en) | Compositions and methods for use thereof in modifying the genomes of microorganisms | |
AU2002350181A1 (en) | Compositions and methods for viral delivery | |
AU2001259564A1 (en) | Pharmaceutical compositions and methods for use | |
AU2002355432A1 (en) | Kavalactone compositions and methods of use | |
AU5931300A (en) | Ringene compositions and methods for use thereof | |
AU2044701A (en) | Polymerase compositions and methods of use thereof |